Similar articles

• Limitations of a meta-analysis investigating the association between cancer and statin use.

  Iwata H, Aoyama T, Kusumi E, Hamaki T, Kami M. Iwata H, et al. Am J Med. 2002 Feb 1;112(2):157-8. doi: 10.1016/s0002-9343(01)01040-3. Am J Med. 2002. PMID: 11835959 No abstract available.
• Statins and cancer: a case of meta-uncertainty.

  Guallar E, Goodman SN. Guallar E, et al. Am J Med. 2001 Jun 15;110(9):738-40. doi: 10.1016/s0002-9343(01)00758-6. Am J Med. 2001. PMID: 11403761 No abstract available.
• Lipid-lowering agents and risk of melanoma.

  Kirsner RS, Ramirez CC, Federman DG, Ma F. Kirsner RS, et al. Int J Cancer. 2005 Nov 1;117(2):333; author reply 334. doi: 10.1002/ijc.21181. Int J Cancer. 2005. PMID: 15900582 No abstract available.
• [Rhabdomyolysis induced by statins].

  Hamano T, Muto T, Kuriyama M. Hamano T, et al. Nihon Naika Gakkai Zasshi. 2007 Aug 10;96(8):1646-51. doi: 10.2169/naika.96.1646. Nihon Naika Gakkai Zasshi. 2007. PMID: 17802715 Review. Japanese. No abstract available.
• [Adverse effects of lipid-lowering medications].

  Fukumoto Y, Shimokawa H. Fukumoto Y, et al. Nihon Rinsho. 2007 Oct 28;65 Suppl 8:165-72. Nihon Rinsho. 2007. PMID: 18074533 Review. Japanese. No abstract available.